Companies / Jade Biosciences, Inc. / Activity
Activity — Jade Biosciences, Inc.
7 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q2 2026 as of | Covestor Ltd 13F manager | New | Common stock | $0 | +17 | 17 <0.01% of shares | low |
| Q1 2026 as of | MAI Capital Management 13F manager | New | Common stock | $85 | +6 | 6 <0.01% of shares | low |
| Q1 2026 as of | Gsa Capital Partners LLP 13F manager | New | Common stock | $275 | +20K | 19,555 0.03% of shares | low |
| Q4 2025 as of | Persistent Asset Partners Ltd 13F manager | New | Common stock | $192.4K | +12K | 12,469 0.02% of shares | low |
| Q2 2025 as of | Barclays PLC 13F manager | New | Common stock | $2.75M | +275K | 274,830 0.43% of shares | low |
| Q1 2026 as of | Balyasny Asset Management L.P. 13F manager | New | Common stock | $5.65M | +402K | 402,489 0.63% of shares | medium |
| Q1 2026 as of | Janus Henderson Group PLC 13F manager | New | Common stock | $43.56M | +3.1M | 3,105,669 4.88% of shares | medium |